Author

Marc R. Hammond

Massachusetts General Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Anat O Stemmer-RachamimoviD· 1 shared Anna L. K. GonyeiD· 1 shared Arvind RaviiD· 1 shared Chip StewartiD· 1 shared Daniel RosebrockiD· 1 shared Dennie Tompers FrederickiD· 1 shared Dimitri G. LivitziD· 1 shared Donald P. LawrenceiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Anat O Stemmer-RachamimovORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

Samuel S. Freeman, Moshe Sade-Feldman, Jaegil Kim, Chip Stewart, Anna L. K. Gonye, Arvind Ravi, Monica B. Arniella, Irena Gushterova, Thomas James LaSalle, Emily M. Blaum, Keren Yizhak, Dennie Tompers Frederick, Tatyana Y. Sharova, Ignaty Leshchiner, Liudmila Elagina, , Nir Hacohen

The paper develops DNA- and RNA-based models combining immune and tumor features to predict outcomes of checkpoint inhibition in melanoma.

Cell Reports Medicine · Feb 1, 2022Peer-reviewedGenomics